Results 161 to 170 of about 220,820 (267)

900 patients evaluated within a median of 1 day from referral in a very early arthritis clinic in France. [PDF]

Rheumatol Adv Pract
Ebstein E, Juge PA, Forien M, Benattar L, Péan de Ponfilly M, Franc M, Léger B, Dupont A, Lemee M, Jessen C, Moret M, Bastard L, Carré L, Mahjoub S, Klimek M, Molto A, Gallais MC, Dousset M, Ottaviani S, Dieudé P.   +19 more
europepmc   +1 more source

Impact of Six‐Month Monitoring Compared to Three‐Month Monitoring of Laboratories During Methotrexate Therapy

Arthritis Care &Research, EarlyView.
Objective To evaluate whether extending the American College of Rheumatology–recommended monitoring interval for complete blood count and liver function tests in patients receiving methotrexate (MTX) affects timely detection of medication‐related toxicity.
Spencer Simko, Ray Zhang, Sohini Mukherjee, Puneet Bajaj, Bonnie L. Bermas   +4 more
wiley   +1 more source

Drug retention of TNF versus IL-23 inhibitors in psoriatic arthritis: a multicenter real-life cohort study. [PDF]

Ther Adv Musculoskelet Dis
Parisi S, Becciolini A, D'Onofrio B, Lo Gullo A, Addimanda O, Magnani M, Reta M, Andracco R, Mansueto N, Del Medico P, Caccavale R, Paroli M, Larosa M, Bianchi G, Camellino D, Raffeiner B, Nucera V, Ianniello A, Giampietro C, Ometto F, Priora M, Molica Colella AB, Bravi E, Platè I, Arrigoni E, Ravagnani V, Bezzi A, Mascella F, Focherini MC, Fiorenza A, Rovera G, Vitetta R, Scolieri P, Bruzzese V, Volpe A, Bixio R, Marchetta A, Lumetti F, Farina A, Bernardi S, Girelli F, Visalli E, Amato G, De Lucia F, Dal Bosco Y, Foti R, Foti R, Serale F, Cipollone F, Di Penta M, Sabatini E, Celletti E, Franchina V, Colella FM, Ferrero G, Sandri G, Giuggioli D, Ditto MC, Fusaro E, Adorni G, Di Donato E, Santilli D, Lucchini G, Ariani A.   +63 more
europepmc   +1 more source

Caregiver Perspectives on the Burden of Disease and Treatment in Uncontrolled Gout

Arthritis Care &Research, EarlyView.
Objective Uncontrolled gout (UG) refers to persistently elevated serum urate (SU) levels >6 mg/dL and ongoing gout symptoms despite use of urate‐lowering therapy (ULT). The objective of this study was to evaluate the burden associated with informal caregiving for individuals with UG.
Angelo Gaffo, Bhavisha Desai, Abiola Oladapo, Nana Kragh, Rebekah Zincavage, Brad Padilla, Naomi Schlesinger   +6 more
wiley   +1 more source

Two lenses, one disease: the power of joint working in SARD-ILD to 'focus' on the best care. [PDF]

Rheumatol Adv Pract
White L, Rodziewicz M, Spencer LG, Perry E.   +3 more
europepmc   +1 more source

Employment Trajectories of Patients with Systemic lupus erythematosus (SLE) and Factors Driving Transitions Between States

Arthritis Care &Research, Accepted Article.
Objective Systemic lupus erythematosus (SLE) significantly impacts employment capacity. This study aimed to investigate the impact of burden of disease activity, damage, and treatment on employment outcomes and transitions in patients with SLE. Materials and Methods Using data from a single center, we analyzed employment transitions, adjusted mean ...
Javier Mencia‐Ledo, Zahi Touma, Laura Whittall Garcia, Dafna Gladman, Behdin Nowrouzi‐Kia   +4 more
wiley   +1 more source

Correction to: The evolving landscape of rheumatic drugs and their indications in paediatric and adolescent care. [PDF]

Rheumatology (Oxford)
europepmc   +1 more source

Single-cell profiling reveals CCL5Hi GZMAHi effector memory CD8 T cell association to oligoarticular JIA. [PDF]

Rheumatology (Oxford)
Lopez-Corbeto M, Guillén Y, Jiménez-Gracia L, Moreno-Ruzafa E, Alvarez-Errico D, Palau N, Martín-Begué N, Heyn H, Julià A, Marsal S.   +9 more
europepmc   +1 more source

Optimizing Hydroxychloroquine Blood Levels and Long‐Term Hydroxychloroquine Intake Could Lower Atherosclerotic Cardiovascular Disease Risk and Prevent Polypharmacy in Systemic Lupus Erythematosus

Arthritis Care &Research, EarlyView.
Objective Hydroxychloroquine (HCQ) is the cornerstone of systemic lupus erythematosus (SLE) management with benefits extending beyond SLE control, including protection against atherosclerotic cardiovascular disease (ASCVD). Although HCQ blood levels reflect recent exposure and long‐term intake reflects medication adherence, the impact of longitudinal ...
Shivani Garg, Murray Urowitz, Charlie Dentz, Niriti Adhikari, Fauzia Hollnagel, Nathalie Costedoat‐Chalumeau   +5 more
wiley   +1 more source

Major Challenges in Rheumatology: Will We Ever Treat Smarter, Instead of Just Harder?

Frontiers in Medicine, 2019
Vasco C. Romão, Vasco C. Romão, João Eurico Fonseca, João Eurico Fonseca   +3 more
doaj   +1 more source